Insider trading

Period: 12 months Stock: ICUI + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

13 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

13 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

13 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

13 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
13 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
13 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

13 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Sep 2026
Sanzone Virginia Ruth VP, General Counsel
Sold on a plan 4×
$819.15K 4,856 at 168.69
25.0%
Planned (10b5-1)
1 Sep 2026
Bonnell Brian Michael Chief Financial Officer
Sold on a plan
$1.12M 6,381 at 175.00
10.2%
Planned (10b5-1)
31 Aug 2026
Bonnell Brian Michael Chief Financial Officer
Sold on a plan 4×
$1.61M 9,307 at 172.79
13.0%
Planned (10b5-1)
13 Aug 2026
Woolson Daniel VP, GM-Infusion Capital
Sold at will
$982.26K 5,417 at 181.33
24.1%
Not planned
12 Aug 2026
Sousa Ben Chief Information Officer
Sold at will
$401.21K 2,250 at 178.32
42.2%
Not planned
11 Aug 2026
Voigtlander Christian B. Chief Operating Officer
Sold at will
$1.63M 8,929 at 182.93
19.3%
Not planned
11 Aug 2026
FINNEY ELISHA W Director
Sold at will
$68.98K 378 at 182.48
7.2%
Not planned
22 May 2026
Woolson Daniel President
Sold at will
$280.68K 2,123 at 132.21
8.6%
Not planned
14 May 2026
Sanzone Virginia Ruth VP, General Counsel
Sold at will
$303.62K 2,447 at 124.08
11.2%
Not planned
12 May 2026
Sold at will
$297.93K 2,424 at 122.91
23.3%
Not planned
25 Nov 2025
Woolson Daniel VP, GM-Infusion Capital
Sold at will
$441.36K 2,897 at 152.35
20.4%
Not planned
11 Nov 2025
FINNEY ELISHA W Director
Sold at will
$180.44K 1,285 at 140.42
24.3%
Not planned
11 Nov 2025
Sanzone Virginia Ruth VP, General Counsel
Sold at will
$132.38K 930 at 142.35
14.6%
Not planned
Showing 1–13 of 13.